FLORES JESSICA
Executive VP & CAO
FLORES JESSICA has filed 9 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, FLORES JESSICA is listed as Executive VP & CAO at Sabra Health Care REIT, Inc. Inside the rolling window, FLORES JESSICA reported no open-market purchases and 1 open-market sale totaling $302K in SBRA.
Companies traded
Other insiders at SBRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$302K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has FLORES JESSICA made?
FLORES JESSICA has filed 9 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does FLORES JESSICA trade?
FLORES JESSICA has filed SEC Form 4 disclosures for 1 company, including SBRA.
When was FLORES JESSICA's most recent SEC Form 4 filing?
FLORES JESSICA's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is FLORES JESSICA's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, FLORES JESSICA is listed as Executive VP & CAO.
What is FLORES JESSICA's total buy and sell value in the current window?
Inside the rolling retention window, FLORES JESSICA bought $0 and sold $302K based on SEC Form 4 filings.
What was FLORES JESSICA's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,231 SBRA shares on 2026-03-25, worth $302K, per SEC Form 4 filings.